RecruitingPhase 2NCT06169046
A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy
Studying Kennedy disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gianni Soraru
- Principal Investigator
- Gianni Sorarù, MD, M.D. Ph.DAzienda Ospedale Università di Padova
- Intervention
- Clenbuterol(drug)
- Enrollment
- 90 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Azienda Ospedale Università di Padova, Padua, PD, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06169046 on ClinicalTrials.govOther trials for Kennedy disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT06862596Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular AtrophyMasahisa Katsuno
- ACTIVE NOT RECRUITINGNCT07443449International SBMA Project (KDA)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGNANCT04944940Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGNANCT03555578Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"Takeda
- RECRUITINGNCT05966038ALS/MND Natural History Study Data RepositoryMassachusetts General Hospital